159 related articles for article (PubMed ID: 29953727)
1. Sinapic acid phenethyl ester as a potent selective 5-lipoxygenase inhibitor: Synthesis and structure-activity relationship.
Touaibia M; Hébert MJG; Levesque NA; Doiron JA; Doucet MS; Jean-François J; Cormier M; Boudreau LH; Surette ME
Chem Biol Drug Des; 2018 Nov; 92(5):1876-1887. PubMed ID: 29953727
[TBL] [Abstract][Full Text] [Related]
2. New Zileuton-Hydroxycinnamic Acid Hybrids: Synthesis and Structure-Activity Relationship towards 5-Lipoxygenase Inhibition.
Chiasson AI; Robichaud S; Ndongou Moutombi FJ; Hébert MPA; Mbarik M; Surette ME; Touaibia M
Molecules; 2020 Oct; 25(20):. PubMed ID: 33066378
[TBL] [Abstract][Full Text] [Related]
3. Structure-Activity Relationship Studies of New Sinapic Acid Phenethyl Ester Analogues Targeting the Biosynthesis of 5-Lipoxygenase Products: The Role of Phenolic Moiety, Ester Function, and Bioisosterism.
Touaibia M; Faye DC; Doiron JA; Chiasson AI; Blanchard S; Roy PP; Surette ME
J Nat Prod; 2022 Jan; 85(1):225-236. PubMed ID: 34995066
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationship of caffeic acid phenethyl ester analogs as new 5-lipoxygenase inhibitors.
Doiron JA; Leblanc LM; Hébert MJ; Levesque NA; Paré AF; Jean-François J; Cormier M; Surette ME; Touaibia M
Chem Biol Drug Des; 2017 Apr; 89(4):514-528. PubMed ID: 27717142
[TBL] [Abstract][Full Text] [Related]
5. Phenolic acid phenethylesters and their corresponding ketones: Inhibition of 5-lipoxygenase and stability in human blood and HepaRG cells.
Mbarik M; Poirier SJ; Doiron J; Selka A; Barnett DA; Cormier M; Touaibia M; Surette ME
Pharmacol Res Perspect; 2019 Oct; 7(5):e00524. PubMed ID: 31523435
[TBL] [Abstract][Full Text] [Related]
6. Caffeic acid phenethyl ester and its amide analogue are potent inhibitors of leukotriene biosynthesis in human polymorphonuclear leukocytes.
Boudreau LH; Maillet J; LeBlanc LM; Jean-François J; Touaibia M; Flamand N; Surette ME
PLoS One; 2012; 7(2):e31833. PubMed ID: 22347509
[TBL] [Abstract][Full Text] [Related]
7. Discovery of a novel 2,5-dihydroxycinnamic acid-based 5-lipoxygenase inhibitor that induces apoptosis and may impair autophagic flux in RCC4 renal cancer cells.
Selka A; Doiron JA; Lyons P; Dastous S; Chiasson A; Cormier M; Turcotte S; Surette ME; Touaibia M
Eur J Med Chem; 2019 Oct; 179():347-357. PubMed ID: 31260889
[TBL] [Abstract][Full Text] [Related]
8. New Hydroxycinnamic Acid Esters as Novel 5-Lipoxygenase Inhibitors That Affect Leukotriene Biosynthesis.
Boudreau LH; Lassalle-Claux G; Cormier M; Blanchard S; Doucet MS; Surette ME; Touaibia M
Mediators Inflamm; 2017; 2017():6904634. PubMed ID: 28680195
[TBL] [Abstract][Full Text] [Related]
9. Substituted Caffeic and Ferulic Acid Phenethyl Esters: Synthesis, Leukotrienes Biosynthesis Inhibition, and Cytotoxic Activity.
Morin P; St-Coeur PD; Doiron JA; Cormier M; Poitras JJ; Surette ME; Touaibia M
Molecules; 2017 Jul; 22(7):. PubMed ID: 28684707
[TBL] [Abstract][Full Text] [Related]
10. Caulerpenyne and related bis-enol esters are novel-type inhibitors of human 5-lipoxygenase.
Richter P; Schubert G; Schaible AM; Cavas L; Werz O; Pohnert G
ChemMedChem; 2014 Aug; 9(8):1655-9. PubMed ID: 24729578
[TBL] [Abstract][Full Text] [Related]
11. Development of novel aminothiazole-comprising 5-LO inhibitors.
M Kretschmer SB; Woltersdorf S; Rödl CB; Vogt D; Häfner AK; Steinhilber D; Stark H; Hofmann B
Future Med Chem; 2016; 8(2):149-64. PubMed ID: 26824797
[TBL] [Abstract][Full Text] [Related]
12. Potent inhibition of human 5-lipoxygenase and microsomal prostaglandin E₂ synthase-1 by the anti-carcinogenic and anti-inflammatory agent embelin.
Schaible AM; Traber H; Temml V; Noha SM; Filosa R; Peduto A; Weinigel C; Barz D; Schuster D; Werz O
Biochem Pharmacol; 2013 Aug; 86(4):476-86. PubMed ID: 23623753
[TBL] [Abstract][Full Text] [Related]
13. Single and multiple inhibitors of the biosynthesis of 5-, 12-, 15-lipoxygenase products derived from cinnamyl-3,4-dihydroxy-α-cyanocinnamate: Synthesis and structure-activity relationship.
Touaibia M; Chiasson AI; Robichaud S; Doiron JA; Hébert MPA; Surette ME
Drug Dev Res; 2024 May; 85(3):e22181. PubMed ID: 38619209
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and evaluation of semi-synthetic triazole-containing caffeic acid analogues as 5-lipoxygenase inhibitors.
De Lucia D; Lucio OM; Musio B; Bender A; Listing M; Dennhardt S; Koeberle A; Garscha U; Rizzo R; Manfredini S; Werz O; Ley SV
Eur J Med Chem; 2015 Aug; 101():573-83. PubMed ID: 26197161
[TBL] [Abstract][Full Text] [Related]
15. Development of 3,5-dinitrobenzoate-based 5-lipoxygenase inhibitors.
Shang E; Liu Y; Wu Y; Zhu W; He C; Lai L
Bioorg Med Chem; 2014 Apr; 22(8):2396-402. PubMed ID: 24685113
[TBL] [Abstract][Full Text] [Related]
16. Optimization of benzoquinone and hydroquinone derivatives as potent inhibitors of human 5-lipoxygenase.
Peduto A; Scuotto M; Krauth V; Roviezzo F; Rossi A; Temml V; Esposito V; Stuppner H; Schuster D; D'Agostino B; Schiraldi C; de Rosa M; Werz O; Filosa R
Eur J Med Chem; 2017 Feb; 127():715-726. PubMed ID: 27836196
[TBL] [Abstract][Full Text] [Related]
17. Identification of 2-mercaptohexanoic acids as dual inhibitors of 5-lipoxygenase and microsomal prostaglandin E₂ synthase-1.
Greiner C; Zettl H; Koeberle A; Pergola C; Northoff H; Schubert-Zsilavecz M; Werz O
Bioorg Med Chem; 2011 Jun; 19(11):3394-401. PubMed ID: 21570310
[TBL] [Abstract][Full Text] [Related]
18. Multitarget drugs: synthesis and preliminary pharmacological characterization of zileuton analogues endowed with Dual 5-LO inhibitor and NO-dependent activities.
Boschi D; Giorgis M; Cena C; Talniya NC; Di Stilo A; Morini G; Coruzzi G; Guaita E; Fruttero R; Gasco A
ChemMedChem; 2010 Sep; 5(9):1444-9. PubMed ID: 20645382
[No Abstract] [Full Text] [Related]
19. Clicked cinnamic/caffeic esters and amides as radical scavengers and 5-lipoxygenase inhibitors.
Doiron JA; Métayer B; Richard RR; Desjardins D; Boudreau LH; Levesque NA; Jean-François J; Poirier SJ; Surette ME; Touaibia M
Int J Med Chem; 2014; 2014():931756. PubMed ID: 25383225
[TBL] [Abstract][Full Text] [Related]
20. Syntheses and evaluation of novel isoliquiritigenin derivatives as potential dual inhibitors for amyloid-beta aggregation and 5-lipoxygenase.
Chen YP; Zhang ZY; Li YP; Li D; Huang SL; Gu LQ; Xu J; Huang ZS
Eur J Med Chem; 2013 Aug; 66():22-31. PubMed ID: 23786711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
